Basaglar ® (insulin glargine injection)

100 units/mL

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

BASAGLAR® (insulin glargine injection): Indication

Basaglar is a long-acting human insulin analog indicated to improve glycemic control.

Detailed Information

Basaglar is a long-acting human insulin analog indicated to improve glycemic control in

  • adults and pediatric patients with T1DM, and

  • adults with T2DM.1

Enclosed Prescribing Information

BASAGLAR® (insulin glargine injection), for subcutaneous use, Lilly

Reference

1. Basaglar [package insert]. Indianapolis, IN: Eli Lilly and Company; 2018.

Glossary

Basaglar = Basaglar® (insulin glargine injection) 100 units/mL

T1DM = type 1 diabetes mellitus

T2DM = type 2 diabetes mellitus

Date of Last Review: August 05, 2019

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 8am - 7pm ET

Or you can

Ask us a question Chat with us

Submit a Request

Visit Us @LillyMedical